Piramal Glass for sale at USD800 million

Indian container and pharmaceutical glassmaker Piramal Glass is for sale.

The company has appointed Bank of America and Axis Capital to find a buyer and has already approached several multi-national glass manufacturers for their interest in an $800 million deal.

Organisations approached include German container and pharmaceutical manufacturer Gerresheimer and French groups Saverglass and Verescence.

Piramal Glass operates four manufacturing plants: two in India, and one each in Sri Lanka and the USA. According to its website it makes 1475 tonnes of glass a day with 12 furnaces and 65 production lines.

It recently completed the first stage of its digital transformation in its plants and worked with companies including Microsoft to implement the new technology.

It makes glass packaging for the global cosmetics, perfumery, skin-care, food, and beverage sectors.

Piramal Glass said: “Piramal Glass India, a privately held company, is exploring a potential equity capital raise from financial partner/s to augment its accelerated growth strategy.

"PGPL believes that there are emerging opportunities arising out of market consolidation which makes it an opportune time to leverage its capabilities for both organic & inorganic growth.”


News material on the Site is copyright and belongs to the Company or to its third party news provider, and all rights are reserved. Any User who accesses such material may do so only for its own personal use, and the use of such material is at the sole risk of the User. Redistribution or other commercial exploitation of such news material is expressly prohibited. Where such news material is provided by a third party, each User agrees to observe and be bound by the specific terms of use applying to such news material. We do not represent or endorse the accuracy or reliability of any of the info contained in any news or external websites referred to in the news.

Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.